Sandoz, a Novartis company, announced that Zarxio (filgrastim-sndz) is now available in the United States. Zarxio is the first biosimilar...
Sandoz, a Novartis company, announced that the FDA approved Zarxio (filgrastim-sndz) (Zarzio in EU) for all indications included in the...
The US Court of Appeal for the Federal Circuit has ruled that Sandoz must wait 180 days from FDA approval...